Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
MRVI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.39B
Close$
$2.14
62.7% downside
Current Fair Value
62.7% downsideOvervalued by 62.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.39 Billion |
|---|---|
| Enterprise Value | $2.35 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.91 |
| Beta | 0.58 |
| Outstanding Shares | 147,996,000 |
Return
| Return on Equity | -37.82% |
|---|---|
| Return on Assets | -12.82% |
| Return on Invested Capital | -17.37% |
Valuation & Multiples
| P/E Ratio | -16.13 |
|---|---|
| PEG | 23.51 |
| Price to Sales | 5.74 |
| Price to Book Ratio | 2.87 |
| Enterprise Value to Revenue | 11.24 |
| Enterprise Value to EBIT | -23.9 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$48.67 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$43.64 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.9371▲ 90.29% |
|---|---|
| Total Calls | 370,200▼ 45.99% |
| Total Puts | 346,900▲ 1382.48% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 83.70%▼ 5.50% |
|---|---|
| Total Invested | $343.73M▼ 18.44% |
| Investors Holding | 165▼ 2.00% |
ESG Score
No data
About Maravai LifeSciences Holdings Inc
3 employeesMaravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are ...